Vimarsana
Biggest News Aggregation in the World

Page 8 - Global Malaria Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Malaria Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Malaria Programme Today - Breaking & Trending Today

WHO urges malaria funding boost as deaths stay stubbornly high - Vimarsana News

WHO urges malaria funding boost as deaths stay stubbornly high

The World Health Organization called Thursday for more funds to help overcome towering challenges in the battle against malaria, which continues to kill hundreds of thousands of mainly African children each year.

WHO unveils new strategy to tackle antimalarial drug resistance in Africa - Vimarsana News

WHO unveils new strategy to tackle antimalarial drug resistance in Africa

WHO unveils new strategy to tackle antimalarial drug resistance in Africa - The Maravi Post

WHO launches new strategy to tackle antimalarial drug resistance in Africa - Vimarsana News

WHO launches new strategy to tackle antimalarial drug resistance in Africa

Some 96% malaria infections and fatalities worldwide in 2020 were from sub-Saharan Africa

Tackling Emerging Antimalarial Drug Resistance in Africa - Vimarsana News

Tackling Emerging Antimalarial Drug Resistance in Africa

Download logoWHO is launching today a new strategy to respond to the urgent problem of antimalarial drug resistance in Africa. The strategy is being

Perennial Malaria Chemoprevention (PMC) – New WHO guidelines and the practicalities of designing and implementing tailored PMC strategies - Vimarsana News

Perennial Malaria Chemoprevention (PMC) – New WHO guidelines and the practicalities of designing and implementing tailored PMC strategies

Perennial malaria chemoprevention (PMC) is newly formulated strategy endorsed in June 2022 by the World Health Organization and builds off the previously recommended but poorly implemented strategy of intermittent preventive treatment of malaria in infants – IPTi. IPTi – the provision of single dose Sulphadoxine Pyrimethamine (SP) delivered through the Expanded Program of Immunization (EPI) at times of childhood immunisation at approximately 3, 4 and 9 months of age was shown to provide infants with protection against malaria, anaemia and all cause hospital admissions.